Company: NCEL
Filing Date: 2025-10-17
Form Type: POS AM
Source: 0001213900-25-099986
Chunk: 63

Company: NewcelX Ltd.
Filing Date: 2025-10-17
Form: POS AM
Chunk 63
---
 and address requests from investors for more detailed information about the types of expenses included in commonly presented expense captions. The new standard is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, with retrospective application permitted. The Company is evaluating the disclosure requirements related to the new standard and its impact on the Company’s consolidated financial statements. The Company has implemented all new accounting pronouncements currently in effect that may impact its consolidated financial statements and does not believe any other recently issued standards will have a material impact on its financial position or results of operations. Annex A-12 NLS PHARMACEUTICS LTD.
NOTES TO THE UNAUDITED INTERIM CONDENSED FINANCIAL STATEMENTS

Note 3

Prepaid Expenses and Other Current Assets:

The Company’s prepaid expenses and other current assets consisted of the following as of June 30, 2025, and December 31, 2024:

|                                                 |     |   | June 30, 
     2025 |     |   | December 31, 
         2024 |
|:------------------------------------------------|:----|:--|---------:|:----|:--|-------------:|
| Vendor prepayments                              |     | $ |   24,330 |     | $ |       65,237 |
| VAT recoverable and other current assets        |     |   |   29,873 |     |   |       49,479 |
| Other short-term receivables                    |     |   |  536,690 |     |   |      400,000 |
| Prepaid insurance                               |     |   |  188,151 |     |   |       42,470 |
| Prepaid expenses                                |     |   |  184,467 |     |   |        2,970 |
| Total prepaid expenses and other current assets |     | $ |  963,511 |     | $ |      560,157 |

Note 4

Other Accrued Liabilities:

Other accrued liabilities consisted of the following as of June 30, 2025, and December 31, 2024:

|                                      |     |   | June 30, 
     2025 |     |   | December 31, 
         2024 |
|:-------------------------------------|:----|:--|---------:|:----|:--|-------------:|
| Professional